Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications
From JAK to CALR: redefining therapeutic targets in myeloproliferative neoplasms.
Journal: Leukemia & lymphoma
Published: April 19, 2026
Ropeginterferon alfa-2b-njft treatment in essential thrombocythemia across different driver mutations: results from a North American, single-arm, multicentre study (EXCEED-ET).
Journal: Lancet regional health. Americas
Published: March 25, 2026
The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysis.
Journal: The Lancet regional health. Southeast Asia
Published: December 09, 2025
Dry needling versus platelet-rich plasma in myofascial pain: A randomized trial.
Journal: Bioinformation
Published: August 01, 2025
The Intersection of Human Factors and Evidence-Based Healthcare Design: A Conceptual Framework.
Journal: HERD
Published: May 26, 2025
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and Outcomes.
The Epidemiology and Impact of Hypoxemia in Sub-Saharan Africa: Prevalence, Practices, and Outcomes.
Journal: Annals of the American Thoracic Society
Published: February 27, 2025
A multicenter study to assess efficacy, safety, and tolerability of ropeginterferon alfa-2b-njft in patients with essential thrombocythemia in the US and Canada: EXCEED-ET trial.
Journal: Frontiers in medicine
Published: January 11, 2025
ECLIPSE-PV: A Randomized, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Two Dosing Regimens of Ropeginterferon Alfa-2b-Njft in Polycythemia Vera.
Journal: Acta haematologica
Published: December 16, 2024
Inter-racial genetic differences in myelofibrosis: a diverse inner-city center analysis.
Journal: Leukemia & lymphoma
Published: October 21, 2024
Last Updated: 09/26/2026